SLC10A1 and infection: Based on this, for subsequent in vitro infection studies, we selected compounds S985852 and A000028897 as potent but non-selective inhibitors as well as compounds S973509 and A000295231 as potent and selective inhibitors of viral preS1-binding to NTCP.